» Articles » PMID: 4564679

In Vitro Response of Human Lymphocytes to Mycoplasma Pneumoniae

Overview
Journal Infect Immun
Date 1972 Apr 1
PMID 4564679
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro culture and stimulation of human peripheral lymphocytes were employed to investigate the role of cellular immunity in Mycoplasma pneumoniae disease. Subjects with documented natural infections served as donors. The lymphocyte response to whole M. pneumoniae organisms was determined as incorporation of tritiated thymidine in a semimicro culture system. The range of cellular reactivity stimulated by specific antigen was within the range stimulated by phytohemagglutinin. The difference between responses of subjects with documented infection and serologically negative controls was highly significant. Specific reactivity of peripheral lymphocytes correlated closely with the presence of serum growth-inhibiting antibodies, and both persisted for several years following infection. Serum complement-fixing titers correlated well with lymphocyte stimulability during the first year but antibody, as measured by this technique, tended to disappear in later convalescence. In light of previous studies, which revealed a lack of correlation between humoral antibodies and resistance to reinfection, these results suggest that immunity to M. pneumoniae infection is mediated by circulating small lymphocytes.

Citing Articles

Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Saraya T, Kurai D, Nakagaki K, Sasaki Y, Niwa S, Tsukagoshi H Front Microbiol. 2014; 5:410.

PMID: 25157244 PMC: 4127663. DOI: 10.3389/fmicb.2014.00410.


Mycoplasma pneumoniae and its role as a human pathogen.

Waites K, Talkington D Clin Microbiol Rev. 2004; 17(4):697-728, table of contents.

PMID: 15489344 PMC: 523564. DOI: 10.1128/CMR.17.4.697-728.2004.


Mycoplasmal infection of lymphocyte cell cultures: infection with M. salivarium.

McGarrity G, Phillips D, Vaidya A In Vitro. 1980; 16(4):346-56.

PMID: 7399547 DOI: 10.1007/BF02618341.


Exfoliation of respiratory epithelium in hamster tracheal organ cultures infected with Mycoplasma pneumoniae.

Murphy G, Brody A, Craighead J Virchows Arch A Pathol Anat Histol. 1980; 389(1):93-102.

PMID: 6779413 DOI: 10.1007/BF00428670.


Delayed hypersensitivity to nonviable Mycoplasma pulmonis in mice is enhanced by dextran sulfate.

Kishima M, KUNIYASU C, Nakagawa M Infect Immun. 1983; 39(2):823-9.

PMID: 6187687 PMC: 348023. DOI: 10.1128/iai.39.2.823-829.1983.


References
1.
Fernald G, CLYDE Jr W, Denny F . Factors influencing growth inhibition of Mycoplasma pneumoniae by immune sera. Proc Soc Exp Biol Med. 1967; 126(1):161-6. DOI: 10.3181/00379727-126-32391. View

2.
CLYDE Jr W . Immunopathology of experimental Mycoplasma pneumoniae disease. Infect Immun. 1971; 4(6):757-63. PMC: 416387. DOI: 10.1128/iai.4.6.757-763.1971. View

3.
NEWBERRY Jr W, Chandler Jr J, CHIN T, Kirkpatrick C . Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol. 1968; 100(2):436-43. View

4.
CLYDE Jr W, Denny F . Mycoplasma infections in childhood. Pediatrics. 1967; 40(4):669-84. View

5.
Biberfeld G, Sterner G . Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971; 79(4):599-605. DOI: 10.1111/j.1699-0463.1971.tb03818.x. View